Stewardship Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$246K Buy
942
+11
+1% +$2.82K 0.05% 155
2026
Q2
$234K Sell
931
-14
-1% -$3.01K 0.05% 159
2026
Q1
$206K Sell
945
-77
-8% -$17.1K 0.05% 162
2025
Q4
$234K Buy
1,022
+71
+7% +$16.2K 0.05% 141
2025
Q3
$220K Buy
+951
New +$194K 0.05% 144
2025
Q2
– Sell
-1,069
Closed -$224K – 152
2025
Q1
$224K Buy
+1,069
New +$208K 0.06% 132

Other funds holding ABBV

Stewardship Advisors's ABBV Position: Q3 2026 in Review

Stewardship Advisors increased its AbbVie (ABBV) stake by 1.2% in Q3 2026, buying an estimated $2.82K and bringing the position to 942 shares worth $246K. The position accounts for 0.05% of the portfolio, ranked #155.

Stewardship Advisors first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 1,918 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Stewardship Advisors held 942 shares of AbbVie worth $246K as of Q3 2026.
  • Stewardship Advisors bought 11 AbbVie shares in Q3 2026, an estimated $2.82K.
  • AbbVie made up 0.05% of Stewardship Advisors's portfolio in Q3 2026, its #155 holding.
  • Stewardship Advisors first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • 1,918 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Stewardship Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.